English | Español
Ruth de Jauregui | Apr 14, 2017

FDA panel reviews license application for potential hemophilia B treatment
Keri Carbaugh | Apr 11, 2017

Proposed rule changes aimed at improving 2018 health insurance choices
John Breslin | Apr 11, 2017

Cancer patient advocates watch health care debate to ensure access to coverage

Ruth de Jauregui | Apr 9, 2017

Bruno Farmaceutici, Orexigen Therapeutics Ireland to distribute Mysimba in Italy
John Breslin | Apr 6, 2017

Gottlieb to Senate committee: FDA must be a 'regulatory watchdog'
Robert Hadley | Apr 5, 2017

European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment
Ruth de Jauregui | Apr 3, 2017

European Medicines Agency recommends Keytruda for approval
Ruth de Jauregui | Apr 3, 2017

Inebilizumab receives orphan status from EMA for optic nerve disorder treatment

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Regulatory
Patient Daily | May 12, 2025

Turning Point USA founder: 'Big pharma’s lobbying of Washington DC has long allowed them to price gouge Americans'